AESKU.GROUP - A safe future thanks to quantitative AESKULISA® SARS-CoV-2 antibody tests
AESKU.GROUP, a leading biotechnology company, based in Wendelsheim, Germany, launched the first quantitative SARS-CoV-2…
AESKU.GROUP, a leading biotechnology company, based in Wendelsheim, Germany, launched the first quantitative SARS-CoV-2…
AESKU.GROUP announced today it completed acquisition of immunofluorescence assay (IFA) specialist MBL BION from MBL Intl…